NOMAD POWER SOLUTIONS, INC. Class of Warrant or Right, Outstanding
NOMAD POWER SOLUTIONS, INC. (NMAD) had Class of Warrant or Right, Outstanding of 3.61 million shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-31
- 2025-12-31: Class of Warrant or Right, Outstanding 3.61M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 3.09M shares.
- 2024-09-30: Class of Warrant or Right, Outstanding 808.37K shares.
- 2024-06-30: Class of Warrant or Right, Outstanding 808.37K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2025-12-31 | 3.61M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 3.09M shares 10-Q · filed 2025-11-12 |
| 2024-09-30 | 808.37K shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 808.37K shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 808.37K shares 10-Q · filed 2024-05-09 |
| 2023-09-30 | 808.37K shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 190.03K shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 1.90M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 1.90M shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 3.40M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 3.40M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 3.11M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 3.11M shares 10-K · filed 2022-03-21 |
| 2021-09-30 | 3.11M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 3.11M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 3.11M shares 10-Q · filed 2021-05-12 |
| 2015-03-31 | 2.93M shares 10-Q · filed 2015-05-13 |
| 2014-12-31 | 2.93M shares 10-K · filed 2015-03-27 |
| 2014-09-30 | 2.93M shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 2.93M shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | 6.83M shares 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |